Colorectal Cancer
Nearly 60 million individuals aged 45 to 85 years are eligible for CRC screening in the US
Researchers estimated that nearly 60 million individuals aged 45 to 85 years are at average-risk for colorectal cancer and eligible for screening in the U.S., according to cross-sectional study data in JAMA Network Open.
CRC rarely found in older adults at surveillance colonoscopy regardless of polyp history
Detection of colorectal cancer was “rare” at surveillance colonoscopy among patients aged 70 to 85 years, and although detection of advanced neoplasia was higher, overall yields did not increase significantly with age, researchers reported.
National Comprehensive Cancer Network appoints board of directors chair, vice chair
Matt Kalaycio, MD, FACP, has been elected chair of National Comprehensive Cancer Network’s board of directors.
Blood-based CRC screening ‘less effective, more costly’ vs. recommended strategies
Triennial blood-based screening for colorectal cancer was not cost-effective compared with existing screening modalities such as colonoscopy, fecal immunochemical test and stool DNA testing, according to microsimulation model projections.
Follow-up measure after stool-based CRC test feasible, could ensure ‘complete’ screening
A quality performance measure that tracks follow-up colonoscopy rates within 6 months of an abnormal stool-based screening test was feasible and had a median reliability of 94.5% across health care organizations, according to researchers.
Prediction model could prioritize high-risk patients awaiting surveillance colonoscopy
A multivariable risk prediction model “may be useful” for prioritizing patients at highest risk for colorectal cancer and awaiting surveillance colonoscopy when demand for the procedure is high, according to research in Gastro Hep Advances.
Coffee consumption may reduce colorectal cancer recurrence, all-cause mortality
Coffee consumption may reduce risk for colorectal cancer recurrence and all-cause mortality, according to research published in the International Journal of Cancer.
Rising incidence of advanced stage CRC in younger adults supports screening at age 45
Incidence rates of distant and regional stage colorectal adenocarcinoma have increased over the past two decades among those aged 46 to 49 years and should be considered when counseling patients on screening initiation, research showed.
‘Additional preventive’ benefit of colonoscopy for CRC falls short of sigmoidoscopy
Colonoscopy screening reduced the incidence of colorectal cancer and related mortality by 30% and 32%, respectively, compared with usual care, although the benefit was less than that of sigmoidoscopy where no screening exists, data showed.
Excess weight may be key driver of early-onset colorectal cancer
Excess body weight may be a key risk factor for the development of early-onset colorectal cancer, according to research published in International Journal of Cancer.